Marlies Mooij

Dr. Marlies Mooij


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2014 in Marine Drugs
Verified
Journal Article
Open access
PDF file
CHCatriona Harrington
Catriona Harrington
JRJerry Reen
Jerry Reen
MMMarlies Mooij
Marlies Mooij
FSFiona A. Stewart
Fiona A. Stewart
JCJean-Baptiste Chabot
Jean-Baptiste Chabot
FOFergal O'gara
Fergal O'gara
The search for new antimicrobial compounds has gained added momentum in recent years, paralleled by the exponential rise in resistance to most known classes of current antibiotics. While modifications of existing drugs have brought some limited clinical success, there remains a critical need for new classes of antimicrobial compound to which key clinical pathogens will be naive. This has provided the context and impetus to marine biodiscovery programmes that seek to isolate and characterize new activities from the aquatic ecosystem. One new antibiotic to emerge from these initiatives is the antibacterial compound tropodithietic acid (TDA). The aim of this study was to provide insight into the bioactivity of and the factors governing the production of TDA in marine Pseudovibrio isolates from a collection of marine sponges. The TDA produced by these Pseudovibrio isolates exhibited potent antimicrobial activity against a broad spectrum of clinical pathogens, while TDA tolerance was frequent in non-TDA producing marine isolates. Comparative genomics analysis suggested a high degree of conservation among the tda biosynthetic clusters while expression studies revealed coordinated regulation of TDA synthesis upon transition from log to stationary phase growth, which was not induced by TDA itself or by the presence of the C10-acyl homoserine lactone quorum sensing signal molecule.

1 July 2014 in Microbiology
Verified
Journal Article
Open access
RMRonan R. McCarthy
Ronan R. McCarthy
MMMarlies Mooij
Marlies Mooij
JRJerry Reen
Jerry Reen
OLOlivier Lesouhaitier
Olivier Lesouhaitier
FOFergal O’gAra
Fergal O’gAra
LysR-type transcriptional regulators (LTTRs) are the most common family of transcriptional regulators found in the opportunistic pathogenPseudomonas aeruginosa. They are known to regulate a wide variety of virulence determinants and have emerged recently as positive global regulators of pathogenicity in a broad spectrum of important bacterial pathogens. However, in spite of their key role in modulating expression of key virulence determinants underpinning pathogenic traits associated with the process of infection, surprisingly few are found to be transcriptionally altered by contact with host cells. BvlR (PA14_26880) an LTTR of previously unknown function, has been shown to be induced in response to host cell contact, and was therefore investigated for its potential role in virulence. BvlR expression was found to play a pivotal role in the regulation of acute virulence determinants such as type III secretion system and exotoxin A production. BvlR also played a key role inP. aeruginosapathogenicity within theCaenorhabditis elegansacute model of infection. Loss of BvlR led to an inability to form tight microcolonies, a key step in biofilm formation in the cystic fibrosis lung, although surface attachment was increased. Unusually for LTTRs, BvlR was shown to exert its influence through the transcriptional repression of many genes, including the virulence-associatedcupAandalggenes. This highlights the importance of BvlR as a new virulence regulator inP. aeruginosawith a central role in modulating key events in the pathogen–host interactome.